A synthetic uracil derivative with antitumor activity through decreasing cyclin D1 and Cdk1, and increasing p21 and p27 in MCF-7 cells

  1. Marchal, J.A.
  2. Núñez, M.C.
  3. Suárez, I.
  4. Díaz-Gavilán, M.
  5. Gómez-Vidal, J.A.
  6. Boulaiz, H.
  7. Rodríguez-Serrano, F.
  8. Gallo, M.A.
  9. Espinosa, A.
  10. Aránega, A.
  11. Campos, J.M.
Aldizkaria:
Breast Cancer Research and Treatment

ISSN: 0167-6806

Argitalpen urtea: 2007

Alea: 105

Zenbakia: 3

Orrialdeak: 237-246

Mota: Artikulua

DOI: 10.1007/S10549-006-9450-2 GOOGLE SCHOLAR